γH2AX DNA Damage Detection Kit: Precise DNA Double-Strand Break Assay

Executive Summary: The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) provides a validated immunofluorescence assay for detecting DNA double-strand breaks (DSBs) in mammalian cells and tissues (APExBIO, K2275 kit). The assay targets γ-H2AX, the phosphorylated form of histone H2AX at serine 139, a rapid and robust biomarker of DSBs and DNA repair events (Xu et al., 2026). The kit supports multiplexed fluorescence microscopy and high-content screening through co-staining with DAPI and Cy5-conjugated secondary antibody, enabling quantification of DNA damage at single-cell resolution. Storage at 4°C or -20°C and light protection are required for optimal reagent stability. APExBIO’s K2275 kit is widely used in genomic instability, apoptosis, DNA repair, and genotoxicity research, including translational and cancer studies (see scenario-driven guidance).

Biological Rationale

DNA double-strand breaks (DSBs) are among the most cytotoxic forms of DNA damage. DSBs arise from exogenous sources such as ionizing radiation, chemotherapeutics, and endogenous processes including replication stress and oxidative metabolism (Xu et al., 2026). Unrepaired or misrepaired DSBs lead to chromosomal aberrations and genomic instability, driving oncogenesis and disease progression. Cellular response to DSBs is orchestrated by the DNA damage response (DDR) pathway, centrally involving ATM and ATR kinases. Upon DSB induction, histone H2AX is rapidly phosphorylated at serine 139, forming γ-H2AX foci at break sites. These foci recruit DNA repair machinery and serve as quantitative markers for DSBs, making γ-H2AX immunofluorescence the gold standard for DSB detection (see strategic insights).

Mechanism of Action of γH2AX DNA Damage Detection Kit (Mouse mAb/Red)

The kit utilizes a mouse monoclonal antibody highly specific for γ-H2AX (phospho-Ser139), ensuring selective detection of DSB-associated chromatin modifications. Following fixation and permeabilization, the primary antibody binds γ-H2AX in nuclear foci. A Cy5-conjugated anti-mouse secondary antibody enables red fluorescent detection, while DAPI counterstaining labels all cell nuclei in blue. Detection is achieved via fluorescence microscopy or high-content screening platforms. Dual-color imaging allows quantification of γ-H2AX foci per nucleus, reflecting DSB burden and spatial distribution. The K2275 kit components include: fixation solution, wash buffer, blocking buffer, γ-H2AX mouse monoclonal antibody, anti-mouse Cy5 secondary antibody, DAPI stain, and mounting medium. Proper storage at 4°C or -20°C, with light protection for fluorophores, maintains reagent integrity (APExBIO product page).

Evidence & Benchmarks

• γ-H2AX immunofluorescence correlates linearly with induced DSBs in mammalian cells exposed to ionizing radiation (Xu et al., Figure 2, https://doi.org/10.2147/IJN.S571116).
• APExBIO’s K2275 kit achieves high signal-to-noise ratios in human, mouse, and rat cells, enabling detection of DSBs at doses as low as 0.1 Gy X-ray exposure (Empowering DNA Damage Research).
• Multiplexed detection using DAPI and Cy5 permits single-cell analysis of DNA damage and co-localization with other markers (Illuminating Genomic Instability).
• Immunofluorescence quantification of γ-H2AX foci is a validated endpoint for genotoxicity testing and DDR pathway analysis in cancer and radiosensitization studies (Xu et al., 2026).
• Benchmarking against comet assay and TUNEL shows superior specificity for DSBs, with minimal background in non-damaged cells (Precise DNA Double-Strand Break Detection).

Applications, Limits & Misconceptions

The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) is optimized for:

• DNA double-strand break detection in mammalian cells and tissues.
• Assessment of DNA damage response (DDR) pathway activation.
• Quantification of apoptosis-associated DNA damage.
• High-throughput genotoxicity and drug screening.
• Cancer research and translational studies on radiosensitization (see Decoding Genotoxic Stress; this article details mechanistic breadth, while the present review emphasizes workflow and benchmarking).

Limitations include specificity for DSBs—single-strand breaks or other DNA lesions are not detected unless they result in DSB intermediates. Quantification requires careful image acquisition and analysis to avoid foci miscounting due to signal overlap. The kit is not validated for plant or non-mammalian samples.

Common Pitfalls or Misconceptions

• γ-H2AX foci form exclusively at DSBs; in reality, some replication or transcription stress may induce foci independent of bona fide DSBs.
• The kit does not detect base modifications, abasic sites, or single-strand breaks directly.
• Improper storage of fluorescent reagents (exposure to light, >4°C) leads to signal loss and increased background.
• Overfixation or underpermeabilization can prevent antibody access, yielding false negatives.
• γ-H2AX signal does not directly quantify repair kinetics unless time-course sampling is performed.

Workflow Integration & Parameters

APExBIO’s K2275 kit is designed for streamlined integration into cell biology and molecular pathology workflows:

• Fixation (10–20 min, room temperature), followed by permeabilization (5–10 min) and blocking (30 min, RT).
• Incubation with primary γ-H2AX antibody (1–2 hours, RT or overnight at 4°C), followed by Cy5 secondary antibody (1 hour, RT, protected from light).
• DAPI counterstaining and mounting for imaging.
• Recommended for use with confocal or widefield fluorescence microscopy, or automated imaging platforms for high-content analysis.
• Sample compatibility: cultured human, mouse, or rat cells; fresh-frozen or paraffin-embedded tissue sections.
• Storage: Most reagents at 4°C; fluorescent antibodies at -20°C, protected from light.

This kit extends the protocols described in earlier articles (Illuminating Genomic Instability) by detailing storage, imaging, and troubleshooting in the context of high-content screening.

Conclusion & Outlook

The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) from APExBIO offers a sensitive, reproducible, and scalable solution for DNA double-strand break detection. Its validated immunofluorescence protocol supports quantitative DNA damage and repair research, translational oncology, and genotoxicity assessment. As DSB detection remains central to genomic instability and DDR pathway research, the K2275 kit is poised to remain a gold-standard tool. Future advances may include multiplexing with additional DDR biomarkers and automation for clinical-scale studies (see strategic outlook).